Yi-Fen Lee, Ph.D

See information for Patients. Viewing information for Researchers.

Contact

University of Rochester
School of Medicine and Dentistry
601 Elmwood Ave, Box 656
Rochester, New York 14642

Office: 585 275-9702 (primary)

Lab: 585 275-9703 (primary)

Portrait

Current Appointments

Education
PhD Endocrinology Univ Wisconsin-Madison 1997
MS Biology Tung-Hai University 1988
BS Biology Tung-Hai University 1986
Post-Doctoral Training & Residency
Lab Manager, Department of Pathology, 1997  2002
Post-Doctoral Fellow, Department of Pathology, 1997  2001
Recent Journal Articles
Showing the 5 most recent journal articles. (11 available)
Chen,T. C.; Persons,K. S.; Zheng,S.; Mathieu,J.; Holick,M. F.; Lee,Y. F.; Bao,B.; Arai,M. A.; Kittaka,A.;. "Evaluation of C-2-substituted 19-nor-1alpha,25-dihydroxyvitamin D(3) analogs as therapeutic agents for prostate cancer". J.Steroid Biochem.Mol.Biol. (2007).
Zhang,Y.; Chen,Y. T.; Xie,S.; Wang,L.; Lee,Y. F.; Chang,S. S.; Chang,C.;. "Loss of Testicular Orphan Receptor 4 Impairs Normal Myelination in Mouse Forebrain". Mol.Endocrinol. (2007).
Ting HJ; Hsu J; Bao BY; Lee YF. "Docetaxel-induced growth inhibition and apoptosis in androgen independent prostate cancer cells are enhanced by 1alpha,25-dihydroxyvitamin D3." Cancer letters. 2007; 247(1):122-9. Epub 2006 Apr 27.
Bao BY; Yeh SD; Lee YF. "1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell invasion via modulation of selective proteases." Carcinogenesis. 2006; 27(1):32-42. Epub 2005 Jun 29.
Bao BY; Yao J; Lee YF. "1alpha, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis." Carcinogenesis. 2006; 27(9):1883-93. Epub 2006 Apr 19.